electroCore Reports First Quarter 2026 Financial Results

electroCore, Inc. announced its financial results for the first quarter of 2026, reporting record net sales of $9.6 million, a 43% increase from the previous year. Despite a net loss of $5.3 million, the company’s Adjusted EBITDA showed a 24% improvement. Growth was attributed to increased prescription sales in the VA and direct-to-consumer sales through their Truvaga brand. The company also reaffirmed its revenue guidance for the full year, emphasizing leadership focus on accelerating growth.